Lori L. Burrows

Jan 14, 2025 | theconversation.com | Lori L. Burrows |Elizabeth Li

La médecine personnalisée se définit comme un traitement adapté à un ou quelques patients atteints de maladies potentiellement mortelles, par exemple un cancer qui ne répond plus à la chimiothérapie ou une infection résistante à plusieurs antibiotiques. Bien que la médecine personnalisée soit prometteuse, elle nécessite une main-d’œuvre importante et coûteuse, et les procédures d’approbation réglementaire et de remboursement sont complexes.

Oct 15, 2024 | goodtimes.ca | Lori L. Burrows |Elizabeth Li |Jessica Dostie

By Lori L. Burrows and Elizabeth C. Li, McMaster UniversityPersonalized medicine describes a treatment tailored to one or a few individuals who have potentially deadly health conditions, such as cancer that no longer responds to chemotherapy, or an infection resistant to multiple antibiotics.

Aug 13, 2024 | theconversation.com | Lori L. Burrows |Elizabeth Li

Personalized medicine describes a treatment tailored to one or a few individuals who have potentially deadly health conditions, such as cancer that no longer responds to chemotherapy, or an infection resistant to multiple antibiotics. Although personalized medicine is promising, it is labour-intensive and expensive, and the pathways for its regulatory approval and reimbursement are complicated, since the small number of patients who qualify limits the design of clinical trials.

Jul 9, 2024 | journalofhospitalinfection.com | Victoria Coles |Thomas Wood |Lori L. Burrows |Laura Puri

SummaryChlorhexidine gluconate (CHG) and povidone-iodine (PI) are commonly used to prevent prosthetic joint infection (PJI) during total joint replacement; however, their effective concentrations and impact on biofilms are not well defined.

Feb 1, 2024 | journals.plos.org | Lori L. Burrows |PLOS Pathogens

Loading metrics Open Access Pearls Pearls provide concise, practical and educational insights into topics that span the pathogens field. See all article types » Citation: Burrows LL (2024) It’s uncomplicated: Prevention of urinary tract infections in an era of increasing antibiotic resistance. PLoS Pathog 20(2): e1011930. https://doi.org/10.1371/journal.ppat.1011930Editor: Jorn Coers, Duke University School of Medicine, UNITED STATESPublished: February 1, 2024Copyright: © 2024 Lori L.